Home › Funds › GREENLEAF TRUST › ABBV

GREENLEAF TRUST position in ABBV

ABBVIE INC · Health Care

GREENLEAF TRUST reported holding 60,041 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$15.7M, representing 0.16% of its reported portfolio and ranking #48 among its reported holdings. GREENLEAF TRUST has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)60.04K sh
Reported value held$15.71M
Portfolio Weight0.16%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GREENLEAF TRUST's ABBV position evolved

GREENLEAF TRUST first disclosed a stake in ABBV in Q3 2023 at 85,711 shares (US$12.8M). The position peaked in Q1 2025 at 107,295 shares, worth US$22.5M. Across 13 filings, GREENLEAF TRUST increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 60,041 shares valued at US$15.7M — a reduction of -659 shares quarter over quarter.. Notable position changes include a 31% trim in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 85.71K $12.78M New
Q4 2023 95.78K $14.84M Add
Q1 2024 96.72K $17.61M Add
Q2 2024 100.53K $17.24M Add
Q3 2024 104.54K $20.64M Add
Q4 2024 110.53K $19.64M Add
Q1 2025 107.30K $22.48M Reduce
Q2 2025 93.37K $17.33M Reduce
Q3 2025 64.70K $14.98M Reduce
Q4 2025 60.67K $13.86M Reduce
Q1 2026 59.74K $12.99M Reduce
Q2 2026 60.70K $15.27M Add
Q3 2026 60.04K $15.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has GREENLEAF TRUST held ABBV?

GREENLEAF TRUST has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GREENLEAF TRUST's current position in ABBV?

As of Q3 2026, GREENLEAF TRUST holds 60.04K shares of ABBV (ABBVIE INC), valued at $15.71M, representing 0.16% of its reported portfolio and ranking #48.

Has GREENLEAF TRUST been buying or selling ABBV?

In the latest 13F filing (Q3 2026), GREENLEAF TRUST reduced its position in ABBV. The position peaked in Q1 2025 at 107.30K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.